MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study
Authors:
- Jelle BarentszJBJelle Barentsz
- 1 September 2008
- journal article
- clinical trial
- Published by Elsevier in The Lancet Oncology
- Vol. 9 (9) , 850-856
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 yearsBJU International, 2007
- Quantitative Detection of Micrometastases in Pelvic Lymph Nodes in Patients with Clinically Localized Prostate Cancer by Real-time Reverse Transcriptase-PCRClinical Cancer Research, 2007
- REGIONAL LYMPH NODE STAGING USING LYMPHOTROPIC NANOPARTICLE ENHANCED MAGNETIC RESONANCE IMAGING WITH FERUMOXTRAN-10 IN PATIENTS WITH PENILE CANCERJournal of Urology, 2005
- The role of lymphadenectomy in prostate cancerNature Reviews Endocrinology, 2005
- Diagnostic Performance of Nanoparticle-Enhanced Magnetic Resonance Imaging in the Diagnosis of Lymph Node Metastases in Patients With Endometrial and Cervical CancerJournal of Clinical Oncology, 2005
- Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate CancerNew England Journal of Medicine, 2003
- WHEN IS PELVIC LYMPH NODE DISSECTION NECESSARY BEFORE RADICAL PROSTATECTOMY? A DECISION ANALYSISJournal of Urology, 2000
- Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.American Journal of Roentgenology, 1996
- Phase I clinical evaluation of a new iron oxide MR contrast agentJournal of Magnetic Resonance Imaging, 1994
- Die computertomographische Stadieneinteilung beim ProstatakarzinomRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1982